Résumé de communication

Objectives: The aim of this meta-analysis is to evaluate the efficacy and safety of the hemostatic suture net in patients undergoing facelift. Introduction: Facelifts are commonly associated with postoperative complications, including hematomas, seromas, infections, necrosis, and skin ischemia. The hemostatic suture net technique has emerged as a promising approach, with the potential to reduce these adverse events. Materials / method: A systematic search was conducted in PubMed, Embase, and Cochrane databases up to May 2025 to identify studies evaluating the use of the hemostatic net in facelift patients. Statistical analysis was performed using R software version 4.4.1, applying a random-effects model for a single-arm meta-analysis, with outcomes reported per 100 observations. The primary outcome was the incidence of hematoma. Secondary outcomes included incidences of seroma, necrosis, ischemia, infection, hyperemic marks associated with the hemostatic net, persistent hyperpigmentation, and sensory deficits. Results: 8 studies were included, comprising 1,617 patients. The outcomes incidences were: hematoma: 0.14 per 100 (95% CI: 0.00 to 0.58; I² = 23.8%); seroma: 2.16 per 100 (95% CI: 0.00 to 9.32; I² = 85.4%); necrosis: 0.36 per 100 (95% CI: 0.00 to 1.14; I² = 3.4%); ischemia: 1.10 per 100 (95% CI: 0.00 to 6.56; I² = 94.7%); infection: 0.62 per 100 (95% CI: 0.00 to 4.35; I² = 70.4%); hyperemic marks: 12.70 per 100 (95% CI: 0.74 to 34.96; I² = 97.5%); persistent hyperpigmentation: 0 per 100 (95% CI: 0.00 to 0.14; I² = 0%); sensory deficits: 0 per 100 (95% CI: 0.00 to 0.33; I² = 0%). Conclusion: Our results suggest that the hemostatic suture net technique may be safe and effective in minimizing postoperative complications in facelift. A minimal incidence of hematoma, seroma, necrosis, ischemia, and infection was observed. Hyperemic marks associated with the technique were initially reported at a moderate incidence but resolved completely within 2 to 3 months, with no progression to persistent hyperpigmentation. Furthermore, no sensory deficits were identified in the evaluated patients.